Olmesartan-associated severe gastritis and enteropathy

BMJ Case Rep. 2018 Dec 10;11(1):e226133. doi: 10.1136/bcr-2018-226133.

Abstract

Olmesartan is an angiotensin II receptor antagonist, used in the treatment of hypertension. We report a case of olmesartan-associated severe gastritis with enteropathy in a 74-year-old woman who presented with mainly upper gastrointestinal symptoms. There was significant endoscopic improvement in the mucosal inflammation on stopping the drug. Subsequent gastroscopy showed mucosal healing and normal gastric and duodenal mucosa. To our knowledge, this is the first case report of olmesartan-associated gastritis and enteropathy predominantly involving and affecting the whole of stomach with limited small bowel involvement.

Keywords: drugs: gastrointestinal system; gastrointestinal system; ulcer.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiotensin II Type 1 Receptor Blockers / adverse effects*
  • Diagnosis, Differential
  • Duodenal Ulcer / chemically induced
  • Duodenal Ulcer / complications
  • Duodenal Ulcer / diagnosis*
  • Duodenal Ulcer / pathology
  • Female
  • Gastritis / chemically induced
  • Gastritis / complications
  • Gastritis / diagnosis*
  • Gastritis / pathology
  • Gastroscopy
  • Humans
  • Hypertension / drug therapy
  • Imidazoles / adverse effects*
  • Severity of Illness Index
  • Tetrazoles / adverse effects*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • Tetrazoles
  • olmesartan